Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,849-1,860 of 4,306
Drug study icon
TerminatedNCT00159757

12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Budapest
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
Hungary
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01568216

20101299: Study Effect of AMG 747 on Schizophrenia Negative Symptoms

This study was terminated in the United States, in Australia, in Canada, .... It focuses on schizophrenia.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Australia, Canada, ...
Sponsor
Amgen
Condition
Schizophrenia
Drug study icon
TerminatedNCT01568229

20110165: Study Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)

This study was terminated in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Amgen
Condition
Schizophrenia
Drug study icon
CompletedNCT00752427

Flexible Doses of Extended Release OROS® Paliperidone for schizophrenia

This study is completed. It is testing Flexible Doses of Extended Release OROS® Paliperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 65 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
TerminatedNCT00946985

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

This study was terminated in the United States, in Canada, in Brazil, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States, Canada, Brazil, ...
Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03003156

50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00018850

5HT3 Antagonism and Auditory Gating in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Denver
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.